BFM
QNRX

Boothbay Fund Management’s Quoin Pharmaceuticals QNRX Stock Holding History

Boothbay Fund Management’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$290K Hold
59,838
– – ﹤0.01% 1748
2026
Q1 		$395K Hold
59,838
– – 0.01% 1475
2025
Q4 		$863K Buy
+59,838
New +$815K 0.01% 862
2025
Q1 		– Sell
-2,306
Closed -$52.5K – 1708
2024
Q4 		$52.5K Buy
+2,306
New +$52.9K ﹤0.01% 1351

Other funds holding QNRX

DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

Boothbay Fund Management's QNRX Position: Q2 2026 in Review

Boothbay Fund Management held its Quoin Pharmaceuticals (QNRX) position steady in Q2 2026 at 59,838 shares worth $290K. The position accounts for ﹤0.01% of the portfolio, ranked #1748.

Boothbay Fund Management first reported a position in QNRX in Q4 2024 and has held it in 4 quarters since. The position peaked at $863K in Q4 2025. 20 funds tracked by Wall St. Rank hold QNRX as of Q2 2026.

  • Boothbay Fund Management held 59,838 shares of Quoin Pharmaceuticals worth $290K as of Q2 2026.
  • Boothbay Fund Management left its Quoin Pharmaceuticals share count unchanged in Q2 2026.
  • Quoin Pharmaceuticals made up ﹤0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1748 holding.
  • Boothbay Fund Management first reported a position in Quoin Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • Boothbay Fund Management's Quoin Pharmaceuticals position peaked at $863K in Q4 2025.
  • 20 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.